Advertisement

Large-Brained Animal Models of Huntington’s Disease: Sheep

  • A. J. MortonEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1780)

Abstract

The limitations of using small-brained rodents to model diseases that affect large-brain humans are becoming increasingly obvious as novel therapies emerge. Huntington’s disease (HD) is one such disease. In recent years, the desirability of a large-brained, long-lived animal model of HD for preclinical testing has changed into a necessity. Treatment involving gene therapy in particular presents delivery challenges that are currently unsolved. Models using long-lived, large-brained animals would be useful, not only for refining methods of delivery (particularly for gene and other therapies that do not involve small molecules) but also for measuring long-term “off-target” effects, and assessing the efficacy of therapies. With their large brains and convoluted cortices, sheep are emerging as feasible experimental subjects that can be used to bridge the gap between rodents and humans in preclinical drug development. Sheep are readily available, economical to use, and easy to care for in naturalistic settings. With brains of a similar size to a large rhesus macaque, they have much to offer. The only thing that was missing until recently was the means of testing their neurological function and behavior using approaches and methods that are relevant to HD. In this chapter, I will outline the present and future possibilities of using sheep and testing as large animal models of HD.

Keywords

Cognition Sleep EEG qEEG Learning Memory 

References

  1. 1.
    Morton AJ, Howland DS (2013) Large genetic animal models of Huntington’s disease. J Huntingtons Dis 2:3–19PubMedGoogle Scholar
  2. 2.
    Cooley RK, Vanderwolf CH (2004) The sheep brain: a basic guide. A.J. Kirby Co., London, CanadaGoogle Scholar
  3. 3.
    Jacobsen JC, Bawden CS, Rudiger SR et al (2010) An ovine transgenic Huntington’s disease model. Hum Mol Genet 19:1873–1882CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Pouladi MA, Morton AJ, Hayden MR (2013) Choosing an animal model for the study of Huntington’s disease. Nat Rev Neurosci 14:708–721CrossRefPubMedGoogle Scholar
  5. 5.
    Menalled L, El-Khodor BF, Patry M et al (2011) Systematic behavioral evaluation of Huntington’s disease transgenic and knock-in mouse models. Neurobiol Dis 35:319–336CrossRefGoogle Scholar
  6. 6.
    Chiang C, Jacobsen JC, Ernst C et al (2012) Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration. Nat Genet 44:390–397CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Huntington’s Disease Sheep Collaborative Research Group (2013) Further molecular characterisation of the OVT73 transgenic sheep model of Huntington’s disease identifies cortical aggregates. J Huntingtons Dis 2:279–295Google Scholar
  8. 8.
    Handley RR, Reid SJ et al (2013) Metabolic disruption identified in the Huntington's disease transgenic sheep model. Sci Rep.  https://doi.org/10.1038/srep20681
  9. 9.
    Handley RR, Reid SJ, Patassini S et al (2016) Metabolic disruption identified in the Huntington’s disease transgenic sheep model. Sci Rep 6:20681CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    DiFiglia M, Sapp E, Chase KO et al (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990–1993CrossRefPubMedGoogle Scholar
  11. 11.
    Vonsattel JP, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577CrossRefPubMedGoogle Scholar
  12. 12.
    Skene DJ, Middleton B, Fraser CF et al (2017) Metabolic profiling of presymptomatic Huntington’s disease sheep reveals novel biomarkers. Sci Rep 7:43030CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Patassini S, Begley P, Xu J et al (2016) Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington’s disease human brain. Biochim Biophys Acta 1862:1650–1662CrossRefPubMedGoogle Scholar
  14. 14.
    van der Burg JM, Bacos K, Wood NI et al (2008) Increased metabolism in the R6/2 mouse model of Huntington’s disease. Neurobiol Dis 29:41–51CrossRefPubMedGoogle Scholar
  15. 15.
    Morton AJ, Wood NI, Hastings MH et al (2005) Disintegration of the sleep-wake cycle and circadian timing in Huntington’s disease. J Neurosci 25:157–163CrossRefPubMedGoogle Scholar
  16. 16.
    Kudo T, Schroeder A, Loh DH et al (2011) Dysfunctions in circadian behavior and physiology in mouse models of Huntington’s disease. Exp Neurol 228:80–90CrossRefPubMedGoogle Scholar
  17. 17.
    Morton AJ (2013) Circadian and sleep disorder in Huntington’s disease. Exp Neurol 243:34–44CrossRefPubMedGoogle Scholar
  18. 18.
    Morton AJ, Rudiger SR, Wood NI et al (2014) Early and progressive circadian abnormalities in Huntington’s disease sheep are unmasked by social environment. Hum Mol Genet 23:3375–3383CrossRefPubMedGoogle Scholar
  19. 19.
    McLennan KM, Skillings EA, Rebelo CJB et al (2015) Validation of an automatic recording system to assess behavioural activity level in sheep (Ovis aries). Small Rum Res 127:92–96CrossRefGoogle Scholar
  20. 20.
    Refenetti R (2016) Circadian physiology, 3rd edn. CRC Press, RatonGoogle Scholar
  21. 21.
    Morton AJ, Avanzo L (2011) Executive decision-making in the domestic sheep. PLoS One 6:e15752CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    McBride SD, Perentos N, Morton AJ (2015) A mobile, high-throughput semi-automated system for testing cognition in large non-primate animal models of Huntington disease. J Neurosci Methods 265:25–33CrossRefPubMedGoogle Scholar
  23. 23.
    Knolle F, McBride S, Goncalves R, Morton AJ (2017) A stop-signal task for sheep: introduction and validation of a direct measure for the stop-signal reaction time. Anim Cogn 20(4):615–626CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Rao AK, Quinn L, Marder KS (2005) Reliability of spatiotemporal gait outcome measures in Huntington’s disease. Mov Disord 20:1033–1037CrossRefPubMedGoogle Scholar
  25. 25.
    Schramke S, Schuldenzucker V, Schubert R et al (2016) Behavioral phenotyping of minipigs transgenic for the Huntington gene. J Neurosci Methods 265:34–45CrossRefPubMedGoogle Scholar
  26. 26.
    Hobbs-Chell H, King AJ, Sharratt H et al (2011) Data-loggers carried on a harness do not adversely affect sheep locomotion. Res Vet Sci 93:549–552CrossRefPubMedGoogle Scholar
  27. 27.
    King AJ, Wilson AM, Wilshin SD et al (2012) Selfish-herd behaviour of sheep under threat. Curr Biol 22:561–562CrossRefGoogle Scholar
  28. 28.
    Strömbom D, Mann RP, Wilson AM et al (2014) Solving the shepherding problem: heuristics for herding autonomous, interacting agents. J R Soc Interface 11:20140719CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Furmston T, Morton AJ, Hailes S (2015) A significance test for inferring affiliation networks from spatio-temporal data. PLoS One 10:e0132417CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Sawiak JS, Perumal SR, Rudiger SR et al (2015) Rapid and progressive regional brain atrophy in CLN6 Batten disease affected sheep measured with longitudinal magnetic resonance imaging. PLoS One 10:e0132331CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Goodman AO, Rogers L, Pilsworth S et al (2011) Asymptomatic sleep abnormalities are a common early feature in patients with Huntington’s disease. Curr Neurol Neurosci Rep 11:211–217CrossRefPubMedGoogle Scholar
  32. 32.
    Lazar AS, Panin F, Goodman AO et al (2015) Sleep deficits but no metabolic deficits in premanifest Huntington’s disease. Ann Neurol 78:630–648CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Goodman AO, Barker RA (2010) How vital is sleep in Huntington’s disease? J Neurol 257:882–897CrossRefPubMedGoogle Scholar
  34. 34.
    Landau ME, Cannard KR (2003) EEG characteristics in juvenile Huntington’s disease: a case report and review of the literature. Epileptic Disord 5:145–148PubMedGoogle Scholar
  35. 35.
    Kantor S, Szabo L, Varga J et al (2013) Progressive sleep and electroencephalogram changes in mice carrying the Huntington’s disease mutation. Brain 136:2147–2158CrossRefPubMedGoogle Scholar
  36. 36.
    Fisher SP, Black SW, Schwartz MD et al (2013) Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington’s disease. Brain 136:2159–2172CrossRefPubMedGoogle Scholar
  37. 37.
    Perentos N, Martins AQ, Cumming R et al (2016a) An EEG investigation of sleep homeostasis in healthy and CLN5 Batten disease affected sheep. J Neurosci 36:8238–8249CrossRefPubMedGoogle Scholar
  38. 38.
    Perentos N, Nicol AU, Martins AQ et al (2016b) Techniques for chronic monitoring of brain activity in freely moving sheep using wireless, longitudinal EEG recording. J Neurosci Methods.  https://doi.org/10.1016/j.jneumeth.2016.11.010
  39. 39.
    Perentos N, Martins AQ, Watson TC, Bartsch U (2015) Translational neurophysiology in sheep: measuring sleep and neurological dysfunction in CLN5 Batten disease affected sheep. Brain 138:862–874CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Nicol AU, Perentos N, Martins AQ, Morton AJ (2016) Automated detection and characterisation of rumination in sheep using in vivo electrophysiology. Physiol Behav 163:258–266CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Physiology, Development and NeuroscienceUniversity of CambridgeCambridgeUK

Personalised recommendations